Rosuvastatin을 중심으로 본 HMG-CoA Reductase Inhibitor간 처방 변경 사유의 분석에 관한 연구
'
Rosuvastatin을 중심으로 본 HMG-CoA Reductase Inhibitor간 처방 변경 사유의 분석에 관한 연구' 의 주제별 논문영향력
| 주제 |
|
|
|---|---|---|
| 동일주제 총논문수 | 논문피인용 총횟수 | 주제별 논문영향력의 평균 |
| 62 | 0 |
0.0% |
주제별 논문영향력
' Rosuvastatin을 중심으로 본 HMG-CoA Reductase Inhibitor간 처방 변경 사유의 분석에 관한 연구' 의 참고문헌
-
Who should receive a statin these days? Lessons from recent clinical trials
-
Systemic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to presentDavid,L. [1982]
-
Successful conversion of patients with hypercholesterolemia from a brand name to a generic cholesterol-lowering drugT.Craig Cheetham [2005]
-
Improving lipid management - to titrate, combine or switchH.Schuster [2002]
-
Guidelines for the Diagnosis and Management of Dyslipidemia남우석 [2003]
-
Drug facts and comparisons, facts & comparisonsCathy,H. [2005]
-
Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy : the DAPISH studyRichard,A. [2005]
-
Clinical and economic outcomes of conversion of simvastatin to lovastatin in a groupmodel health maintenance organizationSarah,J. [2005]
-
A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemiaSaito,Y. [2002]